Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Table of contents
Table of contents
Email alerts
Table of contents
Prev issue
Next issue
November 2020 - Volume 8 - Suppl 3
35th Anniversary Annual Meeting (SITC 2020)
Regular and young investigator award abstracts
Biomarkers, immune monitoring, and novel technologies
Biomarkers, immune monitoring, and novel technologies
Cellular therapies
Cellular therapies
Checkpoint blockade therapy
Checkpoint blockade therapy
Clinical trials completed
Clinical trials completed
Clinical trials in progress
Clinical trials in progress
Combination immunotherapies
Combination immunotherapies
COVID and Immunotherapy
COVID and Immunotherapy
Data sharing, handling, and access
Data sharing, handling, and access
Education and treatment management
Education and treatment management
Immune cell biology
Immune cell biology
Immune cell types
Immune cell types
Immune-stimulants and immune modulators
Immune-stimulants and immune modulators
Immuno-conjugates and chimeric molecules
Immuno-conjugates and chimeric molecules
Immunotherapy toxicities
Immunotherapy toxicities
Machine learning, artificial intelligence, and computational modeling
Machine learning, artificial intelligence, and computational modeling
Microbiome and other environmental factors
Microbiome and other environmental factors
Novel single-agent immunotherapies
Novel single-agent immunotherapies
Other
Other
Regulatory, financial, and access considerations
Regulatory, financial, and access considerations
Tumor and stromal cell biology
Tumor and stromal cell biology
Late-breaking abstracts
Biomarkers, immune monitoring, and novel technologies
Biomarkers, immune monitoring, and novel technologies
Cellular therapies
Cellular therapies
Checkpoint blockade therapy
Checkpoint blockade therapy
Clinical trials completed
Clinical trials completed
Clinical trials in-progress
Clinical trials in-progress
Combination immunotherapies
Combination immunotherapies
COVID and immunotherapy
COVID and immunotherapy
Immune cell biology
Immune cell biology
Immune cell types
Immune cell types
Immune-stimulants and immune modulators
Immune-stimulants and immune modulators
Immunotherapy toxicities
Immunotherapy toxicities
Novel single-agent immunotherapies
Novel single-agent immunotherapies
Other
Other
Tumor and stromal cell biology
Tumor and stromal cell biology
Author index
Author index
Subject index
Subject index
Issue Information
Complete PDF
